These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 15693809

  • 1. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.
    Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O.
    Eur J Neurol; 2005 Mar; 12(3):199-207. PubMed ID: 15693809
    [Abstract] [Full Text] [Related]

  • 2. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
    Ondo WG, Perkins T, Swick T, Hull KL, Jimenez JE, Garris TS, Pardi D.
    Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
    [Abstract] [Full Text] [Related]

  • 3. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V, Dhoat S, Williams AJ, Dimarco A, Pal S, Forbes A, Tobías A, Martinez-Martin P, Chaudhuri KR.
    J Neurol Sci; 2006 Oct 25; 248(1-2):158-62. PubMed ID: 16780888
    [Abstract] [Full Text] [Related]

  • 4. Sleepiness in Parkinson's disease: a controlled study.
    Brodsky MA, Godbold J, Roth T, Olanow CW.
    Mov Disord; 2003 Jun 25; 18(6):668-72. PubMed ID: 12784270
    [Abstract] [Full Text] [Related]

  • 5. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
    Razmy A, Lang AE, Shapiro CM.
    Arch Neurol; 2004 Jan 25; 61(1):97-102. PubMed ID: 14732626
    [Abstract] [Full Text] [Related]

  • 6. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease.
    Dusek P, Busková J, Růzicka E, Majerová V, Srp A, Jech R, Roth J, Sonka K.
    Clin Neuropharmacol; 2010 Jul 25; 33(4):186-90. PubMed ID: 20661025
    [Abstract] [Full Text] [Related]

  • 7. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
    Paus S, Brecht HM, Köster J, Seeger G, Klockgether T, Wüllner U.
    Mov Disord; 2003 Jun 25; 18(6):659-67. PubMed ID: 12784269
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.
    Möller JC, Stiasny K, Hargutt V, Cassel W, Tietze H, Peter JH, Krüger HP, Oertel WH.
    Mov Disord; 2002 May 25; 17(3):474-81. PubMed ID: 12112193
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment.
    Valko PO, Waldvogel D, Weller M, Bassetti CL, Held U, Baumann CR.
    Eur J Neurol; 2010 Dec 25; 17(12):1428-36. PubMed ID: 20491889
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
    Del Dotto P, Gambaccini G, Caneparo D, Berti C, Bernardini S, Bonuccelli U.
    Neurol Sci; 2003 Oct 25; 24(3):170-1. PubMed ID: 14598071
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study.
    Romigi A, Brusa L, Marciani MG, Pierantozzi M, Placidi F, Izzi F, Sperli F, Testa F, Stanzione P.
    J Neurol Sci; 2005 Jan 15; 228(1):7-10. PubMed ID: 15607203
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
    Zibetti M, Rizzone M, Merola A, Angrisano S, Rizzi L, Montanaro E, Cicolin A, Lopiano L.
    Acta Neurol Scand; 2013 May 15; 127(5):e28-32. PubMed ID: 23311399
    [Abstract] [Full Text] [Related]

  • 18. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease.
    Happe S, Baier PC, Helmschmied K, Meller J, Tatsch K, Paulus W.
    J Neurol; 2007 Aug 15; 254(8):1037-43. PubMed ID: 17351722
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study.
    Happe S, Berger K, FAQT Study Investigators.
    J Neurol; 2001 Dec 15; 248(12):1062-7. PubMed ID: 12013583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.